Background: To report palinopsia as a possible side effect of topiramate.
Methods: Case series and review of the literature.
Results: Nine patients in our series, and 4 previously reported patients, who developed palinopsia while on topiramate, are reviewed. All patients were women, and comorbidities included migraine, idiopathic intracranial hypertension, and bulimia nervosa. Palinopsia resolved in 8 patients after stopping or decreasing the dose of topiramate. The lowest dose of topiramate causing palinopsia was 25 mg twice a day. More than half of our patients reported exacerbation of visual disturbance in early morning or late evening.
Conclusions: Topiramate-induced palinopsia may be underdiagnosed because physicians do not inquire about such visual symptoms.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/WNO.0000000000000216 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Topiramate-induced palinopsia: a case series and review of the literature.
J Neuroophthalmol
June 2015
Department of Ophthalmology and Visual Sciences (SHY, RLL), Yale School of Medicine, New Haven, Connecticut; Departments of Neurology, and Ophthalmology and Visual Sciences (PL), Vanderbilt University School of Medicine, Nashville, Tennessee; and Department of Ophthalmology (MS), University of Texas Health Science Center, San Antonio, Texas.
Background: To report palinopsia as a possible side effect of topiramate.
Methods: Case series and review of the literature.
Results: Nine patients in our series, and 4 previously reported patients, who developed palinopsia while on topiramate, are reviewed.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!